Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study
Rebecca J. Chapman, David R. Ghasemi, Felipe Andreiuolo, Valentina Zschernack, Arnault Tauziede Espariat, Francesca Buttarelli, Felice Giangaspero, Jacques Grill, Christine Haberler, Simon M.L. Paine, Ian Scott, Thomas S. Jacques, Martin Sill, Stefan Pfister, John-Paul Kilday, Pierre Leblond, Maura Massimino, Hendrik Witt, Piergiorgio Modena, Pascale Varlet, Torsten Pietsch, Richard G. Grundy, Kristian W. Pajtler, View ORCID ProfileTimothy A. Ritzmann
doi: https://doi.org/10.1101/2022.11.24.22282659
Rebecca J. Chapman
1Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham, UK
David R. Ghasemi
2Hopp Children’s Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany
4Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, 69120 Heidelberg, Germany
Felipe Andreiuolo
5Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany
6Instituto Estadual do Cerebro Paulo Niemeyer
7IDORr Institute, Rio de Janeiro, Brazil
Valentina Zschernack
5Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany
Arnault Tauziede Espariat
9Departement de Neuropathologie, Hopital Sainte-Anne, Paris, France
11INSERM Unit 981 and Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France
Francesca Buttarelli
8Dept. of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University of Rome, Rome Italy
10IRCCS Neuromed, Pozzilli, Italy
Felice Giangaspero
8Dept. of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University of Rome, Rome Italy
10IRCCS Neuromed, Pozzilli, Italy
Jacques Grill
11INSERM Unit 981 and Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France
Christine Haberler
12Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria
Simon M.L. Paine
13Department of Neuropathology, Nottingham University Hospital, Nottingham, UK
Ian Scott
13Department of Neuropathology, Nottingham University Hospital, Nottingham, UK
Thomas S. Jacques
14Developmental Biology and Cancer Programme, UCL GOS Institute of Child Health
15Department of Histopathology, Great Ormond Street Hospital for Children, London, UK
Martin Sill
2Hopp Children’s Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany
Stefan Pfister
2Hopp Children’s Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany
4Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, 69120 Heidelberg, Germany
John-Paul Kilday
16Children’s Brain Tumour Research Network (CBTRN), Royal Manchester Children’s Hospital, Manchester, UK
17The Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer Sciences, University of Manchester, Manchester, UK
Pierre Leblond
18Institute of Hematology and Pediatric Oncology (IHOPe), Leon Berard Comprehensive Cancer Center, Lyon, France
Maura Massimino
19Paediatric Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy
Hendrik Witt
2Hopp Children’s Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany
4Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, 69120 Heidelberg, Germany
Piergiorgio Modena
20Genetics Unit, Pathology Department, Ospedale S. Anna, Como, Italy
Pascale Varlet
9Departement de Neuropathologie, Hopital Sainte-Anne, Paris, France
11INSERM Unit 981 and Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France
Torsten Pietsch
5Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany
Richard G. Grundy
1Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham, UK
Kristian W. Pajtler
2Hopp Children’s Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany
3Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), 69120 Heidelberg, Germany
4Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, 69120 Heidelberg, Germany
Timothy A. Ritzmann
1Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham, UK
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 29, 2022.
Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study
Rebecca J. Chapman, David R. Ghasemi, Felipe Andreiuolo, Valentina Zschernack, Arnault Tauziede Espariat, Francesca Buttarelli, Felice Giangaspero, Jacques Grill, Christine Haberler, Simon M.L. Paine, Ian Scott, Thomas S. Jacques, Martin Sill, Stefan Pfister, John-Paul Kilday, Pierre Leblond, Maura Massimino, Hendrik Witt, Piergiorgio Modena, Pascale Varlet, Torsten Pietsch, Richard G. Grundy, Kristian W. Pajtler, Timothy A. Ritzmann
medRxiv 2022.11.24.22282659; doi: https://doi.org/10.1101/2022.11.24.22282659
Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study
Rebecca J. Chapman, David R. Ghasemi, Felipe Andreiuolo, Valentina Zschernack, Arnault Tauziede Espariat, Francesca Buttarelli, Felice Giangaspero, Jacques Grill, Christine Haberler, Simon M.L. Paine, Ian Scott, Thomas S. Jacques, Martin Sill, Stefan Pfister, John-Paul Kilday, Pierre Leblond, Maura Massimino, Hendrik Witt, Piergiorgio Modena, Pascale Varlet, Torsten Pietsch, Richard G. Grundy, Kristian W. Pajtler, Timothy A. Ritzmann
medRxiv 2022.11.24.22282659; doi: https://doi.org/10.1101/2022.11.24.22282659
Subject Area
Subject Areas
- Addiction Medicine (359)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2702)
- Dermatology (231)
- Emergency Medicine (408)
- Epidemiology (12343)
- Forensic Medicine (10)
- Gastroenterology (774)
- Genetic and Genomic Medicine (4188)
- Geriatric Medicine (394)
- Health Economics (691)
- Health Informatics (2708)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (869)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (447)
- Neurology (3974)
- Nursing (216)
- Nutrition (587)
- Oncology (2093)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1137)
- Primary Care Research (464)
- Public and Global Health (6603)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)